Spectral Edge Frequency From Spectral EEG Analysis to Guide Deep Sedation in the Critical Care Setting (Pilot)
NCT04026451 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2022-11-04
Summary
Critically ill patients under mechanical ventilation (MV) have pain, anxiety, sleep deprivation and agitation. The use of analgesics and sedatives drugs (sedoanalgesia) is a common practice to produce pain relief and comfort during the VM. Despite its usefulness, it has been documented that the excessive use of sedatives is associated with an increased risk of prolonging the stay under MV and in the Intensive Care Unit (ICU). To avoid this, current evidence suggests the use of protocols guided to clinical goals, such as the sedation-agitation scale (SAS), or daily suspension of infusions to avoid excess sedation. These protocols minimize the prescription of deep sedation, which is still necessary for 20-30% of patients.
Monitoring of sedation with electroencephalography in the ICU has been underutilized. In fact, only the use of indices that are generated from algorithms of the electroencephalographic signal processing has been reported. However, it has been shown that the use of these monitoring systems does not benefit the heterogeneous groups of patients in MV. Currently, the clinical monitors used to measure the effect of drugs used in a sedoanalgesia show in the screen the spectrogram of the brain electrical signal and quantify the frequency under which 95% of the electroencephalographic power is located, known as spectral edge frequency 95 (SEF95). This value in a person who is conscious is usually greater than 20 Hz, in a patient undergoing general anesthesia it is between 10 and 15 Hz. In preliminary measurements, in deeply sedated patients in the ICU, SEF95 values are under 5 Hz. This would indicate that patients in the ICU are being overdosed. It is unknown if in cases with an indication of deep sedation, the use of monitoring by spectrogram is superior to the standard management guided at clinical scales, such as SAS.
Therefore, the investigators propose the following hypothesis: In patients with an appropriate indication of deep sedation (SAS 1-2), the sedoanalgesia guided by the spectral edge frequency 95 reduces the consumption of propofol compared to the deep sedoanalgesia guided by the sedation scale agitation in MV patients in the ICU maintaining a clinically adequate level of sedation.
Conditions
- Deep Sedation
- Mechanical Ventilation
Interventions
- DEVICE
-
Sedation guided by SEF95 (10-13 Hz) from SedLine® monitor
Dosage of propofol and fentanyl will be guided by SEF95 value between 10-13 Hz. If SEF95 is lower than 10 Hz, the infusion rate of propofol and fentanyl will be diminished; if SEF95 is higher than 13 Hz, the infusion rate of propofol and fentanyl will be increased; and if SEF95 is between 10-13 Hz, then the infusion rate will be kept.
- BEHAVIORAL
-
Sedation guided by SAS scale (1-2)
Dosage of propofol and fentanyl will be guided by SAS to keep a value of 1-2. If SAS is higher than 1-2, then the infusion rate of propofol and fentanyl will be increased; and if SAS is 1-2, then the infusion rate of propofol and fentanyl will be maintained.
- DRUG
-
Deep sedation with propofol andfentanyl
Propofol and fentanyl will be infused to reach a score in the SAS of 1-2
- PROCEDURE
-
Mechanical Ventilation
Critically ill patients will be ventilated mechanically following the clinical indication.
Sponsors & Collaborators
-
University of Chile
lead OTHER
Principal Investigators
-
Antonello Penna, MD/PhD · University of Chile
-
Rodrigo Gutiérrez, MD · University of Chile
-
Felipe Maldonado, MD · University of Chile
-
José Ignacio Egaña, MD/PhD · University of Chile
-
Eduardo Tobar, MD · University of Chile
-
Verónica Rojas, Nurse/MSc · University of Chile
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-11
- Primary Completion
- 2021-04-01
- Completion
- 2021-04-01
- FDA Device
- Yes
Countries
- Chile
Study Locations
More Related Trials
-
Oxygen Consumption and Sevoflurane Uptake Based on Physiological Dead Space Estimation
NCT05511584 ·Status: UNKNOWN ·Phase: NA
-
A Comparison of Emergence Agitation by Sevoflurane for Intraoperative Sedation Associated With Caudal Block
NCT03134547 ·Status: COMPLETED ·Phase: NA
-
Use of Intraoperative Clonidine for Prevention of Postoperative Agitation in Pedriatic Anesthesia With Sevoflurane.
NCT02181543 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit
NCT01527903 ·Status: COMPLETED ·Phase: PHASE4
-
Sevoflurane- Safety in Long-term Sedation Procedures
NCT01802255 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparison Between Propofol and Fentanyl for Prevention of Emergence Agitation in Children After Sevoflurane Anesthesia
NCT01506622 ·Status: COMPLETED ·Phase: NA
-
Effects of Subanesthetic Isoflurane/Sevoflurane in 60% Oxygen on Clinical In-vitro Experimental Sepsis
NCT02185118 ·Status: UNKNOWN ·Phase: NA
-
A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.
NCT00421720 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy of Fentanyl Citrate in Children
NCT02172014 ·Status: COMPLETED ·Phase: PHASE2
-
Post Extubation Delirium and End-tidal Sevoflurane Concentration
NCT02489734 ·Status: COMPLETED ·Phase: NA
-
Sevoflurane General Anesthetic and Spatial Memory in Humans
NCT05991817 ·Status: RECRUITING
-
Electroencephalogram Based Real-Time Sedation Level Prediction
NCT05757622 ·Status: UNKNOWN
-
An Observational Prospective Study of Anesthetic Sensitivity Assessed by Alpha Band Power and Its Association With Emergence Time From Sevoflurane General Anesthesia in Young Adults.
NCT07254975 ·Status: NOT_YET_RECRUITING
-
Depth of Anesthesia During Electroconvulsive Therapy
NCT05308056 ·Status: COMPLETED
-
Ketamine Versus Propofol as ICU Sedation
NCT06243822 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy
NCT00004424 ·Status: COMPLETED ·Phase: NA
-
Aminophylline and Cognitive Function After Sevoflurane Anaesthesia
NCT01022151 ·Status: COMPLETED ·Phase: PHASE2
-
Propofol Sedation Study
NCT00597740 ·Status: COMPLETED
-
Effects of Sedatives on Sublingual Microcirculation of Patients With Septic Shock
NCT01618396 ·Status: COMPLETED ·Phase: NA
-
Minimum Alveolar Concentration of Sevoflurane With Nitrous Oxide Inducing Isoelectric EEG
NCT01705743 ·Status: COMPLETED ·Phase: PHASE4
-
Sedation, ANalgesia and Delirium MANagement in Intensive Care Unit
NCT05027217 ·Status: COMPLETED
-
The Emergency Department Sedation Pilot Trial
NCT04410783 ·Status: COMPLETED ·Phase: NA
-
Fentanyl and Propofol for Tracheal Intubation During Sevoflurane Induction Without Muscle Relaxants in Children
NCT02442128 ·Status: COMPLETED ·Phase: NA
-
Different Doses of Sevoflurane During Induction of Anesthesia on Emergence Delirium in Children
NCT02707016 ·Status: UNKNOWN ·Phase: NA
-
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
NCT00000259 ·Status: COMPLETED ·Phase: NA